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EDITORIAL REVIEW
Virulence of urinary pathogens
It is widely accepted that the ability of bacteria to adhere to
mucosal surfaces is a prerequisite to the establishment of
infection. Adhesion confers two major benefits on bacteria in
that adherent bacteria overcome the cleansing action of fluid
movement, and they are brought into direct contact with a rich
source of nutrients that may leach from the surface. Some
pathogens go a stage further and invade the mucosal epithelium.
However, those organisms that do gain access to host tissues
may quickly be faced with a formidable obstacle in the form of
polymorphonuclear leukocytes (PMNL) and macrophages. If
the bacteria adhere to the surface membranes of these
phagocytic cells, they are likely to stimulate ingestion, respira-
tory burst activity, and degranulation, and may therefore pro-
voke their own destruction. Phagocytosis is greatly enhanced if
the bacteria become coated with opsonic serum proteins, but
cell-cell interactions can occur in the absence of opsonins,
depending on the physico-chemical surface properties of the
bacterial cells. Clearly, successful pathogens must be able to
adhere to mucosal surfaces but resist ingestion and destruction
by phagocytic cells.
To understand how bacteria interact with epithelial surfaces
and phagocytic cells it is necessary to identify the mechanisms
of adhesion involved with each. Despite a great deal of research
in recent years, however, the nature and significance of bacte-
rial adherence in vivo is still far from clear, particularly with
regard to extraintestinal infections. In many cases, observa-
tions made in vitro are of dubious relevance to what may occur
in vivo. This review will examine how urinary pathogens adhere
to mucosal surfaces and phagocytic cells, and what the possible
outcome of these interactions might be.
Bacterial adherence to bladder epithelium
The bladder luminal surface is covered with a glycoprotein
mucin layer [1, 2], which appears to play an important antibac-
terial role [2, 3]. Disruption of the mucin layer allows bacteria to
colonize the uroepithelial surface in large numbers [4], and this
may be followed by penetration of the epithelium, the initiation
of an inflammatory response, and desquamation of surface
epithelial cells [5], all of which may contribute to the symptom-
atology associated with cystitis [6].
Because the process of adhesion appears to be important in
the initiation of infection, a great deal of attention has been paid
to defining the mechanisms involved. The observation that
bacterial strains isolated from patients with symptomatic uri-
nary tract infections have a high frequency of the genotype
coding for fimbriae which cause mannose-resistant hemaggluti-
nation (MRHA) of human erythrocytes [7—101 led to the hypoth-
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esis that these adhesions are responsible for mediating bacterial
attachment to the bladder wall. Indeed, bacteria with MRHA
activity were found to adhere to isolated human uroepithelial
cells, but not to urinary mucus [11, 12], while purified MRHA
fimbriae were also shown to bind to uroepithelial cells [13].
Several types of adhesion with MRHA activity have been
described, including non-fimbrial adhesions [14, 15], but partic-
ular attention has been paid to the type designated P fimbriae,
which bind to a specific digalactoside residue forming part of
the P blood group antigens [16, 17]. These antigens occur in the
surface membranes of uroepithelial cells and erythrocytes in all
individuals except those with the rare p phenotype. P fimbriate
bacteria adhere strongly to uroepithelial cells isolated from
P-positive subjects, and this adhesion can be blocked by
synthetic receptor analogues [18—20].
Although these observations suggest strongly that fimbriae
are important mediators of adhesion for uropathogens, all the
experimental evidence in favor of this hypothesis was derived
using bacteria that were subcultured in artificial culture media
prior to study. It is well known that fimbrial expression can be
manipulated by altering the conditions for bacterial growth [21],
and so it is imperative to know what type of fimbriae, and
indeed what other surface characteristics, are expressed by
bacteria growing in urine in vivo. When we [6, 22, 23] and
others [24, 25] examined fresh urinary isolates of Escherichia
coli before subculture, it became evident that the bacterial cells
in the great majority of urinary tract infections lacked hemag-
glutination activity and were non-fimbriate, including those
bacteria attached to periurethral or uroepithelial cells [6]. Urine
is, in fact, a poor medium for the expression of fimbriae by
exponentially growing bacteria due to its high osmolality and
low iron content (data to be published), points which can easily
be confirmed by using it as a culture medium in vitro. It follows
that fimbriae are unlikely to participate in bacterial adherence in
the bladder if they are rarely expressed in that environment.
Lack of fimbriation is not the only change in bacterial surface
structure that can occur in the bladder urine. Many different
species of bacteria in vivo have been shown to synthesize a
polysaccharide or glycoprotein capsule or sheath, given the
general name of glycocalyx, which may be lost on subculture
[26—28]. Bacteria grow in microcolonies on the bladder mucosal
surface [29], and glycocalyces may fulfil a number of functions,
including providing a protected environment for growth as well
as serving to anchor the microcolonies to the bladder wall.
Indeed, glycocalyx-mediated adherence to uroepithelial cells
has been demonstrated both in vivo [30, 31] and in vitro [32].
The precise mechanism whereby glycocalyces might mediate
adhesion is not known at present. Because they are hydrophilic
structures with a net negative charge, it might be expected that
there would be a mutual repulsion between them and the
bladder mucin layer or epithelial surface. It is possible, in fact,
that the adherence capabilities of uropathogens are reduced
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when they are enclosed in a glycocalyx. On the other hand, two
polysaccharide surfaces might be brought together by physico-
chemical forces of attraction such as van der Waals effect, and
the surfaces may resist forces of separation ii they are both
wetted by the intervening water layer [33]. This topic warrants
further investigation. Certainly, it is clear that glycocalyces, by
virtue of constituting the outermost surface layer of bacterial
cells in vivo, must have a major influence on the interaction
between bacteria and host cells.
Pyelonephritis and bacterial virulence
Bacteria may ascend the ureters to reach the kidneys by
being carried in films of fluid 134], or more efficiently by a
combination of vesico-ureteric and intrarenal reflux. Growth
conditions in the renal parenchyma might be expected to be
quite different than those in the bladder urine, and it is possible
that fimbriae are expressed in this environment where they
might contribute to virulence, P fimbriation has been shown to
occur with a very high frequency (81 to 94%) in subcultured
strains of E. co/i isolated from children with acute pyelonephri-
tis [17, 19], but the frequency is low among strains causing
cystitis (19%) or asymptomatic bacteriuria (14%) [19]. Clearly,
P fimbriae have a special association with pyelonephritis, but
not with infections of the lower urinary tract.
Despite the undoubted association between P fimbriation and
acute pyelonephritis, there is still no evidence that these
fimbriae, or other MRHA adhesions, play a direct role in
bacterial pathogenicity. It may be that because the genotype for
MRHA activity is closely linked to that coding for hemolysin
production [7, 35, 361, which in turn tends to be associated with
the genotypes for serum resistance [37] and certain 0 serotypes
that commonly occur in urinary isolates [7, 9, 371, that it is
simply a marker of virulence for pyelonephritic strains of E. co/i
and not a cause of virulence. Hemolysin has been shown to
enhance nephropathogenicity by virtue of its ability to make the
iron from erythrocytes available for bacterial growth [38].
Likewise, resistance to the cidal effect of serum must be an
important attribute for any pathogen that is likely to come into
contact with complement proteins [39], while smooth 0 anti-
gens can contribute to bacterial resistance to phagocytosis as
discussed below.
Although many virulence markers and factors can be identi-
fied, it should be borne in mind that virulence is a subjective
concept that can only be assessed in relation to host factors.
This is demonstrated by the recent observation by Lomberg et
al [40] that strains of E. co/i isolated from children with
pyelonephritis possessed a significantly lower frequency of
known virulence markers (including MRHA activity) in the
presence of vesico-ureteric reflux than in its absence, despite
the fact that patients with pyelonephritis and reflux are most
likely to develop renal scars. This shows that the virulence
factors associated with establishing an infection and those
associated with production of tissue damage must be quite
different. Thus, reflux enables poor invaders to reach and
colonize the renal parenchyma, but these bacteria appear to be
more capable of causing scarring than those which would be
regarded as being more virulent by standard criteria.
Because renal scarring is the major pathological feature of
chronic pyelonephritis, it is important to learn more about the
virulence determinants of bacteria associated with tissue dam-
age in the kidney. Bacterial growth per Se, obviously, does not
result in scar formation [41], but there is good evidence that an
inflammatory response is an essential feature [42—44]. This
would suggest that tissue damage and scarring may be caused
by toxic mediators released from inflammatory cells following
stimulation by bacteria or bacterial products. Since the major
function of phagocytic cells in the inflammatory exudate is to
ingest and kill bacteria, it is evident that the interaction between
bacteria and phagocytes must be crucial to the outcome of
infection.
Bacterial interaction with phagocytes
It is well known that bacteria will be phagocytosed efficiently
by PMNL and macrophages if they elicit an immune response
and/or activate complement and so become coated with anti-
body or complement proteins. C3b receptors in the surface
membranes of phagocytic cells mediate attachment, while in-
gestion appears to be a function of the receptors for the Fe
portion of IgG [45—47]. Plasma fibronectin [48] and a variety of
polycations [49, 50] can also act as opsonins, and human urine
has even been shown to possess opsonic activity [51].
In certain microenvironments in vivo, opsonization will in-
evitably be poor or non-existent. The classical pathway of
complement activation could be deficient in the renal paren-
chyma because the ammonia in kidney tissue is a powerful
inhibitor of C4 [52]. Even when exposed to potential opsonins,
many pathogens can evade recognition by virtue of particular
surface characteristics. The hydrophilic or negatively charged
nature of smooth 0 and K antigens can prevent direct associ-
ation of bacteria with the surface membranes of phagocytic
cells [53, 54]. Furthermore, capsules can prevent opsonization
by inhibiting the alternative [55—57] and classical [58] comple-
ment activation pathways. Inhibition of the alternative pathway
appears to be largely dependent on the high capsular content of
sialic acids [59], or the related sugar 2-keto-3-deoxy-octonate
(KDO) [60, 61], which greatly increase the binding affinity of the
inhibitor /31H for C3b [62]. Opsonization by specific antibody
may be deficient because the terminal sialic acid residues of
some capsular polysaccharides, notably K! and KS, are chem-
ically identical to constituents of host gangliosides or glycopro-
teins and hence are poorly immunogenic [61, 63]. It may be,
therefore, that the balance between bacterial elimination and
persistence of infection hinges on the interaction between
phagocytic cells and unopsonized bacteria.
Surface hydrophobicity is an important determinant of the
susceptibility of unopsonized bacteria to phagocytosis, as dem-
onstrated by the observation by van Oss and Gillman [64], that
bacteria are ingested by PMNL if they have a surface that is
more hydrophobic than that of the phagocyte. Type I fimbriae
are also known to mediate attachment of bacteria to the surface
membranes of phagocytic cells [65—68] and to promote
phagocytosis [69, 70], and they can also stimulate respiratory
burst activity [71—74] and release of granule enzymes [71].
Recent studies in this laboratory have shown that Type 1
fimbriate bacteria elicit a unique pattern of degranulation in
human PMNL by causing extracellular release of proteins from
all three major types of granule [75]. We have also found that
the ability of Type 1 fimbriae to stimulate the respiratory burst
in PMNL, as assessed by luminol-dependent chemilumines-
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cence, is mediated partly by their strongly hydrophobic nature
and partly by an interaction with mannose residues in the
PMNL membrane (manuscript in preparation).
PMNL granule proteinases are known to be capable of
degrading connective tissue [76, 77], and the normal balance
between released proteinases and tissue anti-proteinases can be
disrupted as a result of inactivation of the anti-proteinases by
reactive oxygen metabolites [78]. The oxygen metabolites may
also cause direct tissue injury [79—81]. At the present time, we
do not know what surface characteristics are expressed by
bacteria growing in the kidney parenchyma, but if pathogens
were able to stimulate respiratory burst activity and degranula-
tion in phagocytic cells while resisting ingestion, then large
quantities of potentially toxic enzymes and oxygen metabolites
might be released into the surrounding tissue. Possession of
Type 1 fimbriae together with a hydrophilic glycocalyx is likely
to endow a bacterial cell with these properties, and, indeed, a
pyelonephritic strain of E. co/i with this combination of surface
structures has been described [73]. We have observed stimula-
tion of PMNL chemiluminescence and release of granule pro-
teins in vitro provoked by Type 1 fimbriate strains of E. co/i,
some of which were not phagocytosed, and the same strains
induced pronounced renal scarring when inoculated directly
into rat kidneys [82]. These observations offer a biochemical
explanation for the pathogenesis of tissue damage and scar
formation associated with chronic pyelonephritis.
Conc/usion
It is clear that the outcome of infection is determined by the
nature of the interaction between bacteria and host cells, and
that such cell-cell interactions are dependent on the surface
properties of both. A major problem in the investigation of
pathogenic mechanisms is that bacteria have the ability to
modify their surface characteristics in response to different
environmental conditions. Another problem is that many traits
may be linked genetically, and it is no easy matter to determine
whether an observed characteristic plays a direct role in en-
hancing bacterial virulence or is simply co-expressed with a
true virulence factor. Finally, there is the problem of having to
distinguish between virulence factors associated with bacterial
colonization, growth, and survival, and those associated with
damage to host tissue. All these points must be considered in
studies designed to evaluate the role of bacterial adherence in
the initiation of infection, and the role of bacteria-phagocyte
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